Trine Heide Øllegaard - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2018	2
2019	3
2020	1
2022	1
2023	0

Page 1

[Immunotherapy for patients with malignant melanoma and brain metastases].

Simonsen LT, Schmidt AMS, Øllegaard TH, Svane IM, Bastholt L, Luczak AA, Schmidt H. Simonsen LT, et al. Among authors: ollegaard th. Ugeskr Laeger. 2019 Jun 10;181(24):V01190057. Ugeskr Laeger. 2019. PMID: 31267950 Free article. Review. Danish.

Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma.

Pedersen JG, Sokac M, Sørensen BS, Luczak AA, Aggerholm-Pedersen N, Birkbak NJ, Øllegaard TH, Jakobsen MR. Pedersen JG, et al. Among authors: ollegaard th. Cancers (Basel). 2022 Jul 9;14(14):3342. doi: 10.3390/cancers14143342. Cancers (Basel). 2022. PMID: 35884403 Free PMC article.

The real-world impact of modern treatments on the survival of patients with metastatic melanoma.

Donia M, Ellebaek E, Øllegaard TH, Duval L, Aaby JB, Hoejberg L, Køhler UH, Schmidt H, Bastholt L, Svane IM. Donia M, et al. Among authors: ollegaard th. Eur J Cancer. 2019 Feb;108:25-32. doi: 10.1016/j.ejca.2018.12.002. Epub 2018 Dec 31. Eur J Cancer. 2019. PMID: 30605822

Bullous Pemphigoid as an Adverse Reaction to Pembrolizumab: Two Case Reports.

Thomsen K, Diernaes J, Øllegaard TH, Spaun E, Vestergaard C. Thomsen K, et al. Among authors: ollegaard th. Case Rep Dermatol. 2018 Jun 5;10(2):154-157. doi: 10.1159/000489661. eCollection 2018 May-Aug. Case Rep Dermatol. 2018. PMID: 30022934 Free PMC article.

Innate immune cell infiltration in melanoma metastases affects survival and is associated with BRAFV600E mutation status.

Dabrosin N, Sloth Juul K, Bæhr Georgsen J, Andrup S, Schmidt H, Steiniche T, Heide Øllegaard T, Bønnelykke Behrndtz L. Dabrosin N, et al. Among authors: heide ollegaard t. Melanoma Res. 2019 Feb;29(1):30-37. doi: 10.1097/CMR.0000000000000515. Melanoma Res. 2019. PMID: 30299387

Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint Inhibitors.

Pedersen JG, Madsen AT, Gammelgaard KR, Aggerholm-Pedersen N, Sørensen BS, Øllegaard TH, Jakobsen MR. Pedersen JG, et al. Among authors: ollegaard th. Cancers (Basel). 2020 May 30;12(6):1414. doi: 10.3390/cancers12061414. Cancers (Basel). 2020. PMID: 32486146 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results